Skip to main content
BMC Public Health logoLink to BMC Public Health
. 2022 Dec 3;22:2259. doi: 10.1186/s12889-022-14522-w

The determinants of immunization coverage among children aged between 12 and 35 months: a nationwide cross-sectional study in Lao People’s Democratic Republic

Yasunori Ichimura 1,, Naoki Yanagisawa 1, Moe Moe Thandar 1, Chansay Pathammavong 2, Kongxay Phounphenghuk 2, Phonethipsavanh Nouanthong 3, Chankham Tengbriacheu 4, Bouaphane Khamphaphongphane 5, Lauren Elizabeth Franzel-Sassanpour 6, Tae Un Yang 6, Hendrikus Raaijmakers 7, Tomomi Ota 1, Kenichi Komada 1, Masahiko Hachiya 1, Shinsuke Miyano 1
PMCID: PMC9719255  PMID: 36463130

Abstract

Background

Immunization is one of the most important public health interventions for reducing morbidity and mortality in children. However, factors contributing to low immunization coverage are not fully understood in the Lao People’s Democratic Republic (Lao PDR). Therefore, this study aimed to identify factors associated with full immunization coverage among children between 12 and 35 months, providing up-to-date information for immunization programs in Lao PDR.

Methods

We analyzed the subpopulation of a nationwide cross-sectional survey using a multistage cluster sampling procedure to evaluate the measles and rubella seroepidemiology. In addition, we categorized children aged between 12 and 35 months into two groups: “fully immunized” children with a birth dose of Bacillus Calmette and Guérin vaccine, hepatitis B vaccine (Hep B), one and three doses for the measles-containing vaccine (MCV) and pentavalent vaccine and pneumococcal conjugate vaccine (PCV) and “partially immunized” children who missed any dose of vaccine. Immunization coverage was calculated as the ratio of “fully immunized” to the total. We compared the groups’ demographic characteristics and health service utilization as independent variables. Multivariate logistic regression was used to assess the relationship between immunization coverage, various demographic factors, and health service utilization.

Results

Overall, 256 of the 416 targeted pairs were included in the analysis. In total, 67.6% of the children were fully immunized. Childbirth at hospitals or health facilities (adjusted odds ratio: 9.75, 95% confidence interval: 5.72–16.62, p < 0.001) was the predictor of full immunization coverage. The 83 children in the partially immunized groups were attributed to Hep B at birth (46, 55.4%), three doses of PCV (34, 41.0%), and the first dose of the MCV (27, 32.5%).

Conclusion

Our study elucidated that the immunization status among children aged between 12 and 35 months in Lao PDR is satisfactory in improving access to healthcare by strengthening communication with residents regarding health service utilization, and expanding mobile outreach services may play a pivotal role in this endeavor. Further research is warranted to evaluate efforts to increase immunization coverage and target populations with limited access to healthcare.

Keywords: Full immunization, Immunization coverage, Extended program on immunization (EPI), Cross-sectional study, Lao People’s Democratic Republic

Background

It is important to prevent vaccine-preventable diseases through immunization and maintain and improve the population’s health. Immunization protects individuals and reduces the number of such infections in society by improving collective immunity when many people are immunized. The Expanded Program on Immunization (EPI) was initiated in 1974 by the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) to promote vaccination to protect children worldwide against preventable infectious diseases [1]. Initially, tuberculosis, polio, diphtheria, tetanus, whooping cough, and measles were selected for vaccination. Subsequently, with new vaccines added, EPI works with other public health programs to improve the health of all people everywhere [1].

In the Lao People’s Democratic Republic (PDR), the national immunization program launched the measles vaccine in 1982/1984 [25]. However, measles is still endemic due to immunization difficulties and surveillance in remote mountainous areas where most people live. Therefore, a pilot measles campaign targeting children aged 9–59 months was conducted in two provinces in 2000, with the remainder of the country covered in 2001 to improve measles control [2, 6]. In Lao PDR, supplementary immunization activities (SIAs) for measles were performed in 2007 and 2011 [6]. The rubella vaccine was introduced in the 2011 SIA and subsequently included in the National Immunization Program (NIP) in 2012 [6]. Lao PDR introduced a routine second dose of the measles-containing vaccine in the NIP in 2017. In 2019, a subnational immunization campaign was conducted for children aged between 6 months and 10 years [6]. Between 2000 and 2020, hepatitis B, Haemophilus influenza type B, polio (inactivated polio vaccine), pneumococcal bacteria, rotavirus, Japanese encephalitis virus, and human papillomavirus vaccines were introduced into the NIP [6]. The first national multistage random cluster sampling survey to identify the sociodemographic factors affecting immunization was conducted in 2014. Following the survey, the national EPI conducted two SIAs specifically on measles. The Eighth National Health Sector Development Plan 2016–2020 aims for at least 90% immunization coverage by 2020. Interventions to increase routine immunization coverage and to improve access to vaccines have been implemented in Lao PDR, for example, by developing cold chains to build the capacity of healthcare workers to deliver vaccines [7]. Conversely, the measles and hepatitis B vaccines (Hep B) administered at birth in 2019 were still low, at approximately 70% [8]. Therefore, there is a need to conduct a national survey to evaluate the interventions implemented recently and broaden the understanding of the factors influencing child immunization.

Methods

Aim and design of the study

This analysis was conducted to identify the factors for achieving full immunization among children aged between 12 and 35 months in a subpopulation of the nationwide cross-sectional study conducted in June 2019 in Lao PDR. This study aimed to estimate population-based immunity against measles, rubella, and other diseases. Therefore, we set the expected measles and rubella immunoglobulin G (IgG) seroprevalence at 60% for 1–2-year-olds and 90% for children 5 years and older, level of confidence at 95%, a margin of error at 0.05, design effect at 1.6, and response rate at 99%, based on a previous study in Lao PDR [3]. The estimated sample size was 416 and 312 participants for 1–2 years old and children 5 years and older, respectively. We used a probability proportional to size sampling based on the multistage cluster method. First, 26 districts were randomly selected as primary sampling units from all districts in Lao PDR. Next, two villages were randomly selected as secondary sampling units from each district, resulting in 52 villages (Fig. 1). Subsequently, eight pairs of children and their caretakers were randomly selected after listing all residents in each village. In this study, we targeted a subpopulation of these 1–2-year-olds and their caregivers.

Fig. 1.

Fig. 1

The map of selected 52 villages. This figure shows the selected 52 villages on the stratified multistage cluster method. Twenty-six districts were randomly selected as primary sampling units from all districts in Lao PDR using probability proportional to size (PPS), and two villages were selected as secondary sampling units from each district using PPS (in total, 52 villages)

Data collection

A survey team comprising two surveyors and one supervisor conducted face-to-face interviews and collected demographic information, immunization coverage, and other relevant information using structured questionnaires. Before each interview, written consent was obtained from the children’s caretakers. In addition, each child’s immunization card or mother and child health handbook were checked against the recommended EPI immunization schedule. We excluded immunization history from the caretaker’s memory because it is unreliable. Table 1 shows the recommended EPI immunization in Lao PDR during data collection. Japanese encephalitis vaccine (JEV) and rubella-containing vaccines were excluded from the full immunization assessment because they were introduced into routine immunization. However, the program is being expanded in a phase-based manner [9]. All collected data were double-entered and cleaned using a Microsoft Excel 2017 spreadsheet.

Table 1.

Routine childhood immunization and recommended age in Lao PDR

Vaccine Age
Hepatitis B Birth
BCG*1 Birth
DTP-Hib-HepB*2 6, 10, and 14 weeks
OPV*3 6, 10, and 14 weeks
IPV*4 14 weeks
PCV*5 6, 10, and 14 weeks
JEV*6 9 months
Measles/rubella 9 and 12–18 months

*1 BCG, Bacillus Calmette-Guérin vaccine; *2 DTP-Hib-Hep, diphtheria, tetanus, pertussis, Haemophilus Influenza, and hepatitis B vaccine; *3 OPV, oral polio vaccine; *4 IPV, inactivated polio vaccine; *5 PCV, pneumococcal conjugate vaccine; *6 JEV, Japanese encephalitis vaccine

Definition of study variables

In this study, the dependent variable was immunization coverage obtained from immunization records. The immunization coverage was categorized into two groups: “fully immunized” children who received a birth dose of the Bacillus Calmette and Guérin vaccine (BCG) and Hep B; one dose of the measles-containing vaccine; and three doses of the pentavalent vaccine containing diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenza (DPT-Hib-HepB), Polio vaccine, and pneumococcal conjugate vaccine (PCV) and “partially immunized” children who missed any vaccine dose. Immunization coverage was calculated as the ratio of “fully immunized” to the total. In addition, we compared demographic characteristics, health service utilization, and source of information factors in children as independent variables between the fully immunized and partially immunized groups.

Missing vaccines were also assessed based on the vaccine history to identify the gap between partial and full immunization.

Data entry and statistical analysis

Somers’ Delta was used for continuous variables with clustered non-normal distribution to assess the relationship between immunization coverage and determinants relevant to immunization coverage. Crude odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression. Multivariate logistic regression analysis was performed for all significant factors with cluster-robust standard errors. Due to the high multicollinearity among the variables, the variable “immunization in outreach in the village” was excluded from the final multivariate logistic regression model. Furthermore, the backward stepwise selection was applied with the elimination of variables with a significance level of 0.05 from the full model. Statistical significance was set at P < 0.05. Statistical analyses were conducted using STATA version 16 (Stata Corp., College Station, TX, USA).

Ethical considerations

This survey was reviewed and approved by the ethical committee of the Ministry of Health, Lao PDR (06/NECHR) and the Institutional Review Board of the National Center for Global Health and Medicine, Japan (NCGM-G-003038-00). The study described was conducted following the Declaration of Helsinki for experiments involving humans. In addition, the Ministry of Health and provincial and district government authorities arranged access to the selected households. Informed consent was obtained from all adults and children’s caretakers. After the trained surveyors explained the objectives and methodology of the study, consent was obtained from each participant. The selected children and their caretakers were given the option not to participate.

Results

Study profile

Data from 256 pairs of children aged 12–35 months and their caretakers were analyzed. We targeted 416 pairs of children and their caretakers to participate; 160 pairs were deemed ineligible for analysis for the following reasons: the number of children in the village was less than the planned 8 (a total of 15 in five villages); 29 pairs did not participate; 13 did not meet the age criteria (< 12 or > 35 months old); 5 participated outside the protocol; 98 pairs had no immunization records, including immunization cards or mother and child health handbooks.

Based on the reported information and verification by immunization records, 173 (67.6%) and 83 (32.4%) children were fully and partially immunized, respectively. No significant differences were observed in the demographic characteristics between the two groups of children (Table 2).

Table 2.

Family characteristic-related and health service utilization factors of childhood vaccination status

Fully immunized Partially immunized Bivariate analysis Multivariable analysis
Crude odds ratio 95% CIa p-value Adjusted odds ratio 95% CIa p-value
Number 173 83
67.6 (61.5–73.3) % 33.4 (26.7–38.5) %
Sex of children
 Boy 87 (66.4%) 44 (33.6%) 0.91 0.59–1.39 0.66
 Girl 85 (68.5%) 39 (31.5%) References
Median of maternal age (years) (IQRb) 28 (24–33) 29 (25–33) 0.82
Maternal ethnicity
 Laolum 110 (69.2%) 49 (30.8%) 1.23 0.57–2.64 0.59
 Non-Laolum 62 (64.6%) 34 (35.4%) References
Maternal occupation
 Farmer 125 (64.1%) 70 (35.9%) 0.49 0.20–1.21 0.12
 Not farmer 47 (78.3%) 13 (21.7%) References
Maternal education
 Primary school 82 (68.3%) 38 (31.7%) 1.05 0.54–2.05 0.88
 More than primary school 90 (67.2%) 44 (32.8%) References
Median of maternal age (years) (IQRb) 31 (27–37) 31 (27–37) 0.66
Paternal ethnicity
 Laolum 110 (70.5%) 46 (29.5%) 1.36 0.62–2.95 0.44
 Non-Laolum 60 (63.8%) 34 (36.2%) References
Paternal occupation
 Farmer 109 (64.1%) 61 (35.9%) 0.56 0.26–1.19 0.13
 Not farmer 61 (76.3%) 19 (23.7%) References
Paternal education
 Primary school 54 (65.1%) 29 (34.9%) 0.82 0.49–1.36 0.44
 More than primary school 116 (69.5%) 51 (30.5%) References
Median number of family members (IQRb) 6 (4–7) 6 (4–8) 0.19
Median number of children (< 15 years old)c (IQRb) 2 (2–3) 2 (2–3) 0.02*
House location
 Fixed 65 (84.4%) 12 (15.6%) 3.61 1.64–7.95 0.001*
 Others 105 (60%) 70 (40%) References
Median time taken to reach the nearest health facilities (minutes)d (IQRb) 20 (10–30) 20 (10–30) 0.18
 Within 15 minutes 85 (74.6%) 29 (25.4%) 1.80 0.83–3.90 0.14
 More than 15 minutes 88 (62.0%) 54 (38.0%) References
Birthplace of children
 Hospital + Health facility 157 (78.1%) 44 (21.9%) 8.70 5.30–14.28 < 0.0001* 9.75 5.72–16.62 < 0.001*
 Others 16 (29.1%) 39 (70.9%) References References
Place to receive vaccination
 Hospital + Health facility 136 (73.9%) 48 (26.1%) 2.75 1.14–6.68 0.03*
 Others 36 (50.7%) 35 (49.3%) References
Received vaccination in outreach in the village
 Yes 77 (59.2%) 53 (40.8%) 0.46 0.22–0.94 0.03*
 No 95 (76%) 30 (24%) References

a CI confidence interval

b IQR interquartile range

c The mean number of children less than 15 years old was 2.3 with a standard deviation of 1.2 in the fully immunized group and 2.7 with a standard deviation of 1.4 in the partially immunized group

d The mean time taken to reach the nearest health facilities was 26.9 minutes with a standard deviation of 25.4 in the fully immunized group and 33.9 minutes with a standard deviation of 38.6 in the partially immunized group

* p < 0.05 was considered statistically significant

Factors associated with immunization coverage

The fully immunized group had fewer children < 15 years (2.3 ± 1.2 vs. 2.7 ± 1.4, p-value: 0.02), and residence on a fixed site had a significant association with full immunization compared to others, such as mobile (OR: 3.61, 95% CI: 1.64–7.95, p-value: 0.001) (Table 2).

Among health service utilization factors, childbirth and immunization at hospitals or health facilities (OR: 8.70, 95% CI: 5.30–14.28, p < 0.0001) and (OR: 2.75, 95% CI: 1.14–6.68, p-value: 0.03), respectively, were positively associated, and immunization in outreach in the village (OR: 0.46, 95% CI: 0.22–0.94, p-value: 0.03) was negatively associated with full immunization coverage (Table 2). No significant differences were observed in the sources of information for immunization and immunization dates (Table 3).

Table 3.

Source of information on vaccination and vaccination date

Fully immunized Partially immunized Bivariate analysis
Crude odds ratio 95% CIa p-value
Source of information on vaccination
 From medical staff
  Yes 144 (68.6%) 66 (31.4%) 1.29 0.57-2.94 0.54
  No 27 (62.3%) 16 (37.7%) References
 From village health volunteer
  Yes 95 (63.3%) 55 (36.7%) 0.68 0.37-1.25 0.22
  No 71 (71.7%) 28 (28.3%) References
 From information written on the vaccination card
  Yes 64 (68.1%) 30 (31.9%) 1.11 0.56-2.19 0.77
  No 100 (65.8%) 52 (34.2%) References
 From family member
  Yes 25 (67.6%) 12 (32.4%) 1.05 0.40-2.74 0.92
  No 139 (66.5%) 70 (33.5%) References
 From friends
  Yes 13 (68.4%) 6 (31.6%) 1.07 0.36-3.19 0.90
  No 150 (67.0%) 74 (33.0%) References
 From radio/TV
  Yes 20 (57.1%) 15 (42.9%) 0.60 0.29-1.27 0.18
  No 144 (68.9%) 65 (31.1%) References
 From poster
  Yes 11 (64.7%) 6 (35.3%) 0.89 0.30-2.59 0.83
  No 153 (67.4%) 74 (32.6%) References
 From village head
  Yes 84 (61.8%) 52 (38.2%) 0.59 0.33-1.07 0.08
  No 82 (73.2%) 30 (26.8%) References
 From women’s union
  Yes 19 (52.8%) 17 (47.2%) 0.50 0.25-0.996 <0.05
  No 146 (69.1%) 65 (30.9%) References
Source of information on vaccination date
 From medical staff
  Yes 114 (70.4%) 48 (29.6%) 1.35 0.76-2.42 0.31
 No 58 (63.7%) 33 (36.3%) References
 From village health volunteer
  Yes 98 (63.2%) 57 (36.8%) 0.70 0.37-1.31 0.26
  No 64 (71.1%) 26 (28.9%) References
 From the information written on the vaccination card
  Yes 65 (71.4%) 26 (28.6%) 1.42 0.70-2.88 0.34
  No 97 (63.8%) 55 (36.2%) References
 From family member
  Yes 26 (66.7%) 13 (33.3%) 1.01 0.41-2.49 0.98
  No 136 (66.3%) 69 (33.7%) References
 From friends
  Yes 9 (64.3%) 5 (35.7%) 0.89 0.27-2.96 0.85
  No 153 (66.8%) 76 (33.2%) References
 From radio/TV
  Yes 5 (55.6%) 4 (44.4%) 0.61 0.14-2.69 0.52
  No 157 (67.1%) 77 (32.9%) References
 Froom poster
  Yes 106 (66.7%) 53 (33.3%) 1.05 0.57-1.94 0.87
  No 57 (65.5%) 30 (34.5%) References
 From village head
  Yes 18 (54.5%) 15 (45.5%) 0.55 0.24-1.29 0.17
  No 145 (68.4%) 67 (31.6%) References
 From woman’s union
  Yes 41 (70.7%) 17 (29.3%) 1.29 0.54-3.04 0.57
  No 120 (65.2%) 64 (34.8%) References
 From megaphone
  Yes 13 (54.2%) 11 (45.8%) 0.56 0.17-1.86 0.34
  No 148 (67.9%) 70 (32.1%) References
 From an official letter from the district governor
  Yes 4 (80%) 1 (20%) 2.03 0.22-18.96 0.54
  No 158 (66.4%) 80 (33.6%) References

a CI confidence interval

The multivariate logistic regression model revealed that childbirth at a hospital or health facility (AOR: 9.75, 95% CI: 5.72–16.62, p < 0.001) was significantly associated with complete immunization coverage (Table 2).

Missing vaccines in the partially immunized group

Of the 83 children in the partially immunized group, 46 (55.4%) did not receive the Hep B at birth, 34 (41.0%) had not completed three doses of PCV, and 27 (32.5%) had not received their first measles vaccination. In contrast, 70 (84.3%), 67 (80.7%), and almost all (82, 98.8%) had received three doses of the pentavalent vaccine, completed three doses of polio vaccination, and received the BCG vaccine, respectively.

Discussion

To the best of our knowledge, this is the first study to examine the immunization coverage nationwide among children aged 12–35 months using multistage cluster sampling and investigate the determinants of full immunization with a birth dose of Hep B after introducing recently implemented efforts to improve vaccination.

Our study indicated that childbirth at a hospital or health facility was significantly associated with complete immunization. This is related to access to health services, which is similar to previous studies in Lao PDR [1014]. Lao PDR is ethnically diverse, including 49 ethnic groups, most of whom live in rural and remote mountainous areas, with limited communication, transport, and social service provision [15]. Therefore, access to health services remains a significant barrier to immunization coverage. In addition, comprehensive and appropriate information dissemination is important for immunization against EPI-covered diseases [16]. The utilization of micro-planning for immunization sessions and the activities of mobile teams have also been suggested to be successful in providing routine immunization [5]. Therefore, adapting these activities to local conditions is necessary to improve immunization coverage.

However, the proportion of children (173 children, 67.6%) who were fully immunized was lower than the national target of 90%. The definition and rates of full immunization varied among studies in Southeast Asian (SEA) countries. Previous studies have reported complete immunization rates of 59.0–80.8%, 79.3–86.4%, and 55.4% in Lao PDR [14, 16, 17], Malaysia [18, 19], and Myanmar [20], respectively. Several factors are associated with immunization coverage in SEA countries. Sociodemographic characteristics affecting complete immunization are the number of children in the family, child’s age, child’s ethnicity, mother’s age, mother’s ethnicity, mother’s religion, mother’s education, mother’s occupation, father’s education, father’s occupation, zone of residence, travel time to health facilities, and willingness to pay for immunization [14, 1622]. Health system and service utilization factors, including mother’s antenatal care attendance, tetanus vaccination during pregnancy, and delayed immunization schedule, are also associated with immunization coverage [18, 20]. Here, the univariate analysis showed that non-residency in a fixed house and a greater number of children were associated with partial immunization. However, several countermeasures have been explored to improve vaccine coverage. In low- and middle-income countries, education may be more effective than incentives to increase vaccination [23]. Similarly, it has been suggested that soft skills, including communication by community outreach teams regarding immunization activities in Lao PDR, also help residents’ vaccine acceptance [13]. Therefore, the effective utilization of the health system and services should also be considered to achieve the national target of full immunization.

Here, full immunization was defined as having received eight doses of vaccines included in the WHO definition of full immunization (one dose of BCG vaccine, three doses of the polio vaccine, three doses of diphtheria-tetanus-pertussis vaccine, and one dose of measles-containing vaccine) [24], plus a birth dose of Hep B and three doses of PCVs considering the vaccine introduction situation in Lao PDR [8]. In addition, the following vaccines were identified as factors contributing to partial immunization: a birth dose of Hep B, three doses of PCVs, and one dose of measles-containing vaccine, and non-coverage rates for these vaccines were similar to those previously reported [8, 25]. Furthermore, the immunization coverage we identified was similar to that previously reported (59.0–80.1%) [14, 16]; however, differences in the definition of full immunization may have had an impact.

The strength of our study is that we surveyed individuals with documented immunization records on a nationwide scale and selected participants using random sampling, which has the advantage of accurately assessing the situation throughout the country. However, this study had some limitations. First, the survey has the advantage of being able to assess immunization status on a national scale; however, groups with varying immunization statuses, including ethnic minorities, may be elusive. For example, in Lao PDR, a measles outbreak was reported in 2019 in an ethnic minority group with low immunization coverage. Therefore, national policies should recognize this heterogeneity. Second, this study analyzed subpopulations of the nationwide measles and rubella seroepidemiological survey. Therefore, the study design and sample size followed this survey, which assessed measles and rubella immunity nationwide. Thirdly, against the targeted 416 pairs, 256 pairs were finally included in the analysis and 160 pairs were excluded from the analysis. Among them, 98 pairs without vaccination records were excluded from the analysis. Therefore, although the current situation requires immunization records, including those used in this study, the results may have selection bias [13]. However, the issues raised in our study warrant further investigation into subgroups of ethnic minorities using mobile device apps for immunization records.

Conclusions

Our study elucidated that the immunization status among children aged between 12 and 35 months in Lao PDR is satisfactory in improving access to healthcare by strengthening communication with residents regarding health service utilization, and expanding mobile outreach services may play a pivotal role in this endeavor. Further research is warranted to evaluate efforts to increase immunization coverage and target populations with limited access to healthcare.

Acknowledgments

I would like to express my deepest gratitude to Anonh Xeuatvongsa for his supervision of this study. We express our sincere gratitude to all the health authorities of Lao PDR and to the children and their caregivers who participated in this study.

Abbreviations

Lao PDR

Lao People’s Democratic Republic

DTP-Hib-HepB

Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemophilus Influenza

PCV

Pneumococcal conjugate vaccine

AOR

Adjusted odds ratio

CI

Confidence interval

EPI

Extended program on immunization

WHO

World Health Organization

UNICEF

United Nations Children’s Fund

SIAs

Supplementary immunization activities

NIP

National Immunization Program

MCV

Measles-containing vaccine

JEV

Japanese Encephalitis Vaccine

BCG

Bacillus Calmette and Guérin vaccine

Hep B

Hepatitis B vaccine

SEA

Southeast Asian

Authors’ contributions

YI supervised the survey, analyzed and interpreted the data, and drafted the manuscript. NY conceived and designed the experiments, drafted the manuscript. MMT drafted the manuscript and interpreted the data. CP conceived and designed the experiments, supervised the survey, and analyzed and interpreted the data. KP, PN, CT and BK conceived and designed the experiments, and supervised the survey. LEFS, TUY, and HR conceived and designed the experiments. TO collected and analyzed data. KK conceived and designed the experiments, and analyzed and interpreted the data. MH conceived and designed the experiments, analyzed and interpreted the data, and wrote the paper. SM conceived and designed the experiments, supervised the whole process of the survey, and analyzed and interpreted the data. All authors read and approved the final manuscript.

Funding

This work was supported by grants from the National Center for Global Health and Medicine (19A01 and 22A01).

Availability of data and materials

The data supporting the present study’s findings are available from the corresponding author, Yasunori Ichimura, on reasonable request.

Declarations

Ethics approval and consent to participate

The survey was reviewed and approved by the ethical committee of the Ministry of Health, Lao PDR (06/NECHR) and the Institutional Review Board of the National Center for Global Health and Medicine, Japan (NCGM-G-003038-00). The work described was carried out in accordance with the Declaration of Helsinki for experiments involving humans. The Ministry of Health and provincial and district government authorities arranged access to the selected households. Informed consent was obtained from all adults and children’s caretakers. After the trained surveyors explained the objectives and methodology of the study, consent was obtained from each participant. Selected children and their caretakers were given the option not to participate.

Consent for publication

Not applicable.

Competing interests

The authors declare no conflict of interest.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.World Health Organization. Essential Programme on Immunization. no date. https://www.who.int/teams/immunization-vaccines-and-biologicals/essential-programme-on-immunization. Accessed 1 Mar 2022.
  • 2.McFarland JW, Mansoor OD, Yang B. Accelerated measles control in the western Pacific region. J Infect Dis. 2003;187(Suppl 1):S246–S251. doi: 10.1086/368039. [DOI] [PubMed] [Google Scholar]
  • 3.Hachiya M, Miyano S, Mori Y, Vynnycky E, Keungsaneth P, Vongphrachanh P, et al. Evaluation of nationwide supplementary immunization in Lao People’s Democratic Republic: population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine. PLoS One. 2018;13:e0194931. doi: 10.1371/journal.pone.0194931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Phimmasane M, Douangmala S, Koffi P, Reinharz D, Buisson Y. Factors affecting compliance with measles vaccination in Lao PDR. Vaccine. 2010;28:6723–6729. doi: 10.1016/j.vaccine.2010.07.077. [DOI] [PubMed] [Google Scholar]
  • 5.Phoummalaysith B, Yamamoto E, Xeuatvongsa A, Louangpradith V, Keohavong B, Saw YM, et al. Factors associated with routine immunization coverage of children under one year old in Lao People’s Democratic Republic. Vaccine. 2018;36:2666–2672. doi: 10.1016/j.vaccine.2018.03.051. [DOI] [PubMed] [Google Scholar]
  • 6.World Health Organization. Summary of Supplementary Immunization Activities from 2000 to 2020. 2020. https://www.who.int/immunization/monitoring_surveillance/data/Summary_Measles_SIAs.xls. Accessed 4 Aug 2021.
  • 7.Gavi, the Vaccine Alliance. Lao PDR: Q&A with manager for the National Expanded Programme on Immunization; 2020. no date. https://www.gavi.org/news/media-room/lao-pdr-qa-manager-national-expanded-programme-immunization. Accessed 1 Mar 2022.
  • 8.World Health Organization and United Nations Children’s Fund. Lao People’s Democratic Republic: WHO and UNICEF estimates of immunization coverage: 2019 revision. 2020.
  • 9.PATH. In Laos, an old partnership makes new progress against COVID-19 2022. no date. https://www.path.org/articles/laos-old-partnership-makes-new-progress-against-covid-19/. Accessed 1 Mar 2022.
  • 10.Black AP, Nouanthong P, Nanthavong N, Souvannaso C, Vilivong K, Jutavijittum P, et al. Hepatitis B virus in the Lao People’s Democratic Republic: a cross sectional serosurvey in different cohorts. BMC Infect Dis. 2014;14:457. doi: 10.1186/1471-2334-14-457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Rheingans R, Anderson JD, Bagamian KH, Pecenka CJ. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People’s Democratic Republic. Vaccine. 2018;36:7868–7877. doi: 10.1016/j.vaccine.2018.02.009. [DOI] [PubMed] [Google Scholar]
  • 12.Sein C, Tiwari T, Macneil A, Wannemuehler K, Soulaphy C, Souliphone P, et al. Diphtheria outbreak in Lao People’s Democratic Republic, 2012-2013. Vaccine. 2016;34:4321–4326. doi: 10.1016/j.vaccine.2016.06.074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sychareun V, Rowlands L, Vilay P, Durham J, Morgan A. The determinants of vaccination in a semi-rural area of Vientiane City, Lao People’s Democratic Republic: a qualitative study. Health Res Policy Syst. 2019;17:2. doi: 10.1186/s12961-018-0407-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Xeuatvongsa A, Hachiya M, Miyano S, Mizoue T, Kitamura T. Determination of factors affecting the vaccination status of children aged 12-35 months in Lao People’s Democratic Republic. Heliyon. 2017;3:e00265. doi: 10.1016/j.heliyon.2017.e00265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nagpal S, Masaki E, Pambudi ES, Jacobs B. Financial protection and equity of access to health services with the free maternal and child health initiative in Lao PDR. Health Policy Plan. 2019;34(Supplement_1):i14–i25. doi: 10.1093/heapol/czz077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kitamura T, Komada K, Xeuatvongsa A, Hachiya M. Factors affecting childhood immunization in Lao People’s Democratic Republic: a cross-sectional study from nationwide, population-based, multistage cluster sampling. Biosci Trends. 2013;7:178–185. [PubMed] [Google Scholar]
  • 17.Maekawa M, Douangmala S, Sakisaka K, Takahashi K, Phathammavong O, Xeuatvongsa A, et al. Factors affecting routine immunization coverage among children aged 12-59 months in Lao PDR after regional polio eradication in western Pacific region. Biosci Trends. 2007;1:43–51. [PubMed] [Google Scholar]
  • 18.Krishna D, Mohd Zulkefli NA, Md Said S, Mahmud A. Sociodemographic and health care factors in determining immunization defaulters among preschool children in Petaling District, Selangor: a cross-sectional study in Malaysia. BMC Public Health. 2019;19:1275. doi: 10.1186/s12889-019-7561-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lim KK, Chan YY, Noor Ani AA, Rohani J, Siti Norfadhilah ZA, Santhi MR. Complete immunization coverage and its determinants among children in Malaysia: findings from the National Health and morbidity survey (NHMS) 2016. Public Health. 2017;153:52–57. doi: 10.1016/j.puhe.2017.08.001. [DOI] [PubMed] [Google Scholar]
  • 20.Nozaki I, Hachiya M, Kitamura T. Factors influencing basic vaccination coverage in Myanmar: secondary analysis of 2015 Myanmar demographic and health survey data. BMC Public Health. 2019;19:242. doi: 10.1186/s12889-019-6548-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hefele L, Syphan S, Xayavong D, Homsana A, Kleine D, Chanthavilay P, et al. Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People’s Democratic Republic: a cross-sectional study. PLoS One. 2020;15:e0242502. doi: 10.1371/journal.pone.0242502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hefele L, Xaydalasouk K, Kleine D, Homsana A, Xayavong D, Syphan S, et al. Seroprevalence of measles and rubella antibodies in vaccinated and unvaccinated infants in the Lao People’s Democratic Republic. Int J Infect Dis. 2021;108:524–530. doi: 10.1016/j.ijid.2021.06.016. [DOI] [PubMed] [Google Scholar]
  • 23.Johri M, Pérez MC, Arsenault C, Sharma JK, Pai NP, Pahwa S, et al. Strategies to increase the demand for childhood vaccination in low- and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ. 2015;93:339–346C. doi: 10.2471/BLT.14.146951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.World Health Organization. Technical notes. Childhood immunization. 2018. https://cdn.who.int/media/docs/default-source/gho-documents/health-equity/state-of-inequality/technical-notes/health-equity-childhood-immunization.pdf. Accessed 1 Mar 2022.
  • 25.Satzke C, Dunne EM, Choummanivong M, Ortika BD, Neal EFG, Pell CL, et al. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine. 2019;37:296–305. doi: 10.1016/j.vaccine.2018.10.077. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data supporting the present study’s findings are available from the corresponding author, Yasunori Ichimura, on reasonable request.


Articles from BMC Public Health are provided here courtesy of BMC

RESOURCES